{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:18:38Z","timestamp":1790867918942,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1006\/biol.2001.0295","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T18:54:13Z","timestamp":1033930453000},"page":"229-232","source":"Crossref","is-referenced-by-count":11,"title":["Mapping of Natural Anti-Factor VIII Antibodies in Plasma Pools from Healthy Donors: Use of Rationally Designed Synthetic Peptides"],"prefix":"10.1006","volume":"29","author":[{"given":"Mario","family":"Di Giambattista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Branckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Laub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/biol.2001.0295_RF1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/312337a0","article-title":"Structure of human factor VIII","volume":"312","author":"Vehar","year":"1984","journal-title":"Nature"},{"key":"10.1006\/biol.2001.0295_RF2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bi00350a035","article-title":"Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry"},{"key":"10.1006\/biol.2001.0295_RF3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood.V86.2.797.bloodjournal862797","article-title":"A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin","volume":"86","author":"Schwartz","year":"1995","journal-title":"Blood"},{"key":"10.1006\/biol.2001.0295_RF4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1471-0528.1997.tb12036.x","article-title":"Acquired haemophilia, an unusual cause of severe postpartum haemorrhage","volume":"104","author":"Kadir","year":"1997","journal-title":"Br J Obst Gynaecol"},{"key":"10.1006\/biol.2001.0295_RF5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0609.1997.tb00733.x","article-title":"Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor","volume":"59","author":"Michiels","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1006\/biol.2001.0295_RF6","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1073\/pnas.89.9.3795","article-title":"Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals","volume":"89","author":"Algiman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/biol.2001.0295_RF7","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI117489","article-title":"Healthy subjects produce both anti-Factor VIII and specific anti-idiotypic antibodies","volume":"94","author":"Gilles","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1006\/biol.2001.0295_RF8","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V95.11.3435","article-title":"Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG","volume":"95","author":"Moreau","year":"2000","journal-title":"Blood"},{"key":"10.1006\/biol.2001.0295_RF9","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0037-1615080","article-title":"A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detection factor VIII:C inhibitors in the haemophilia A population of Canada","volume":"79","author":"Giles","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1006\/biol.2001.0295_RF10","first-page":"347","article-title":"Prediction of surface and interior regions in proteins\u2014part I: linear tripeptide sequences identify structural boundaries in proteins","volume":"4","author":"Parker","year":"1991","journal-title":"Peptide Res"},{"key":"10.1006\/biol.2001.0295_RF11","first-page":"355","article-title":"Prediction of surface and interior regions in proteins\u2014part II: predicting secondary structure in regions bound by surface exposed regions","volume":"4","author":"Parker","year":"1991","journal-title":"Peptide Res"},{"key":"10.1006\/biol.2001.0295_RF12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0038-1655911","article-title":"Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate","volume":"77","author":"Peerlinck","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1006\/biol.2001.0295_RF13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-2478(88)90076-4","article-title":"An assessment of prediction methods for locating continuous epitopes in proteins","volume":"17","author":"Van Regenmortel","year":"1988","journal-title":"Immunol Lett"},{"key":"10.1006\/biol.2001.0295_RF14","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.V89.7.2413","article-title":"A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin","volume":"89","author":"Pemberton","year":"1997","journal-title":"Blood"},{"key":"10.1006\/biol.2001.0295_RF15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V96.3.979","article-title":"Hemophilic factor VIII C1- and C2-domain missense mutations and their modelling to the 1\u00b75-angstrom human C2-domain crystal structure","volume":"96","author":"Liu","year":"2000","journal-title":"Blood"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105601902957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105601902957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:08:37Z","timestamp":1583413717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105601902957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":15,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S1045105601902957"],"URL":"https:\/\/doi.org\/10.1006\/biol.2001.0295","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}